Ac. Anderson et al., The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design, J MOL BIOL, 297(3), 2000, pp. 645-657
Thymidylate synthase from Pneumocystis carinii (PcTS) is an especially impo
rtant drug target, since P. carinii is a fungus that causes opportunistic p
neumonia infections in immune-compromised patients and is among the leading
causes of death of AIDS patients. Thymidylate synthase (TS) is the sole en
zyme responsible for the de novo production of deoxythymidine monophosphate
and hence is crucial for DNA replication in every organism. Inhibitors sel
ective for P. carinii TS over human TS would be greatly beneficial in comba
ting this disease. The crystal structure of TS from P. carinii bound to its
substrate, dUMP, and a cofactor mimic, CB3717, was determined to 2.6 Angst
rom resolution. A comparison with other species of TS shows that the volume
of the closed PcTS active-site is 20 % larger than that of five other TS c
losed active-sites. A two-residue proline insert that is strictly conserved
among all fungal species of TS, and a novel C-terminal closing interaction
involving a P. carinii-specific tyrosine residue are primarily responsible
for this increase in volume. The structure suggests several options for de
signing an inhibitor specific to PcTS and avoiding interactions with human
TS. Taking advantage of the residue substitutions of P. carinii TS over hum
an TS enables the design of a selective inhibitor. Additionally, the larger
volume of the active-site of PcTS is an important advantage for designing
de novo inhibitors that will exclude the human TS active-site through steri
c hindrance. (C) 2000 Academic Press.